Return to Search
EN
Achalasia (swallowing difficulty) management has evolved over time, encompassing various therapeutic approaches. Historically, medical treatments such as medications and botulinum toxin (Botox) injections were employed. However, due to the high incidence of side effects associated with pharmacological interventions and the need for repeat Botox applications every 4-6 months, these methods are less frequently preferred in contemporary practice.
Currently, the primary treatment modalities for achalasia are endoscopic dilation (specifically, balloon dilation of the narrowed lower esophagus) and surgical intervention. Endoscopic dilation is often considered a first-line treatment due to its minimally invasive nature, shorter recovery period, absence of surgical scars, and quicker return to normal daily activities. While its long-term success rate may be lower than surgery, requiring multiple sessions in some patients, it offers significant immediate advantages. Notably, for pediatric patients under 9-10 years of age, surgery is frequently the initial preferred approach.
Among surgical options, the Heller Esophagocardiomyotomy, first described approximately a century ago, remains the most effective treatment, performed with various modern modifications. This procedure can be conducted via abdominal or thoracic approaches, utilizing either open or laparoscopic techniques. The surgery involves incising the constricted muscle fibers at the lower esophageal sphincter, thereby reducing esophageal pressure and alleviating dysphagia. To mitigate the common post-operative complication of gastroesophageal reflux disease (GERD), many surgeons concurrently perform an anti-reflux procedure. The success rate for this surgical treatment is reported to be over 85-90%. Patients typically experience a relatively short hospital stay, averaging 3-4 days after laparoscopic surgery and 6-7 days after open surgery.
What is the treatment for achalasia (difficulty swallowing)?
Currently, the primary treatment modalities for achalasia are endoscopic dilation (specifically, balloon dilation of the narrowed lower esophagus) and surgical intervention. Endoscopic dilation is often considered a first-line treatment due to its minimally invasive nature, shorter recovery period, absence of surgical scars, and quicker return to normal daily activities. While its long-term success rate may be lower than surgery, requiring multiple sessions in some patients, it offers significant immediate advantages. Notably, for pediatric patients under 9-10 years of age, surgery is frequently the initial preferred approach.
Among surgical options, the Heller Esophagocardiomyotomy, first described approximately a century ago, remains the most effective treatment, performed with various modern modifications. This procedure can be conducted via abdominal or thoracic approaches, utilizing either open or laparoscopic techniques. The surgery involves incising the constricted muscle fibers at the lower esophageal sphincter, thereby reducing esophageal pressure and alleviating dysphagia. To mitigate the common post-operative complication of gastroesophageal reflux disease (GERD), many surgeons concurrently perform an anti-reflux procedure. The success rate for this surgical treatment is reported to be over 85-90%. Patients typically experience a relatively short hospital stay, averaging 3-4 days after laparoscopic surgery and 6-7 days after open surgery.